1 active not recruiting, 1 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow ILD: new trials by email Literature Review of ILD trials Research Report on ILD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rituximab Therapy in Patients With Treatment Refractory Hypersenstivity Pneumonitis Rituximab (Mabthera) - Hypersenstivity Pneumonitis, ILD | Phase 2 | Completed | Shereen Medhat Mohammed Elsayed Nassar | 30 | 2023-06-01 | 2025-06-25 |
| Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease Xenon-129 - ILD | Phase 1 / Phase 2 | Active not recruiting | Children's Hospital Medical Center, Cincinnati | 78 | 2022-04-14 | 2026-02-13 |
Children's Hospital Medical Center, Cincinnati (1) · Shereen Medhat Mohammed Elsayed Nassar (1)
Egypt (1) · United States (1)
Rana K Gabr, MD in Chest Diseases (1) · Safy Z. Kaddah, Professor of Chest Diseases (1) · Sherin M. Nassar, MSc in Chest Diseases (1) · Yosri M. Akl, Professor of Chest Diseases (1) · Zack Cleveland, PhD (1)